Stock SONN SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sonnet BioTherapeutics Holdings, Inc.

Equities

SONN

US83548R3030

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 21:00:00 21/05/2024 BST 		5-day change 1st Jan Change
1.65 USD -5.17% Intraday chart for Sonnet BioTherapeutics Holdings, Inc. -8.84% -5.17%
03-11 Traders Anticipate Inflation Report as US Equities Open Lower on Wall Street MT
03-11 Top Premarket Gainers MT

Valuation

Fiscal Period: September 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 35.06 35.24 7.174 5.015 5.065 - -
Enterprise Value (EV) 1 35.06 35.24 7.174 5.015 5.065 5.065 5.065
P/E ratio - -0.59 x -0.21 x -0.16 x -0.76 x -0.65 x -
Yield - - - - - - -
Capitalization / Revenue - 72.9 x 20.5 x 33.9 x 30.5 x - -
EV / Revenue - 72.9 x 20.5 x 33.9 x 30.5 x - -
EV / EBITDA - - - - -0.34 x - -
EV / FCF - -1.56 x - - -0.33 x -0.24 x -0.18 x
FCF Yield - -64% - - -302% -417% -555%
Price to Book - - - - - - -
Nbr of stocks (in thousands) 44.3 189 222 1,750 3,070 - -
Reference price 2 791.6 186.6 32.34 2.865 1.650 1.650 1.650
Announcement Date 17/12/20 17/12/21 15/12/22 14/12/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 0.4836 0.3499 0.1478 0.166 - -
EBITDA 1 - - - - -15 - -
EBIT 1 - -25.09 - -18.79 -14.15 -17.48 -28
Operating Margin - -5,187.32% - -12,714.04% -8,525.9% - -
Earnings before Tax (EBT) 1 - -24.98 - -18.83 -12.99 -13.94 -
Net income 1 - -24.98 - -18.83 -12.99 -19.28 -28
Net margin - -5,165.92% - -12,741.15% -7,824.7% - -
EPS 2 - -314.2 -150.5 -18.14 -2.170 -2.520 -
Free Cash Flow 1 - -22.56 - - -15.3 -21.1 -28.1
FCF margin - -4,663.87% - - -9,216.87% - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 17/12/20 17/12/21 15/12/22 14/12/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 0.1298 0.0953 0.0621 0.0628 0.0373 0.0364 0.0368 0.0373 0.0186 - 0.057 0.056
EBITDA - - - - - - - - - - - -
EBIT 1 -6.215 -8.21 -7.867 - - - - -3.6 -1.279 -3.869 -3.879 -3.979
Operating Margin -4,788.1% -8,613.32% -12,674.77% - - - - -9,662.24% -6,864.57% - -6,805.26% -7,105.36%
Earnings before Tax (EBT) 1 -6.201 -8.208 -7.877 - - - - -3.677 -1.169 0.3654 -3.879 -3.979
Net income 1 -6.201 -8.208 -7.877 - - - - -3.677 -1.169 0.3654 -3.879 -3.979
Net margin -4,777.33% -8,611.52% -12,690.54% - - - - -9,867.79% -6,272.2% - -6,805.26% -7,105.36%
EPS 2 -30.80 -43.12 -40.04 -37.18 -17.60 -7.480 -2.860 -17.28 -0.3100 0.0700 -0.8433 -0.6400
Dividend per Share - - - - - - - - - - - -
Announcement Date 08/02/22 10/05/22 15/08/22 15/12/22 13/02/23 10/05/23 14/08/23 14/12/23 14/02/24 14/05/24 - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - -22.6 - - -15.3 -21.1 -28.1
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex 1 - - - - 0.2 0.2 0.2
Capex / Sales - - - - 120.48% - -
Announcement Date 17/12/20 17/12/21 15/12/22 14/12/23 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.65 USD
Average target price
11.5 USD
Spread / Average Target
+596.97%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SONNET BIOTHERAPEUTICS HOLDINGS, INC. Stock Sonnet BioTherapeutics Holdings, Inc.
-5.17% 5.34M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+37.78% 705B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.82% 583B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.51% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.94% 332B
ABBVIE INC. Stock AbbVie Inc.
+5.14% 291B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.64% 238B
ROCHE HOLDING AG Stock Roche Holding AG
-4.13% 210B
NOVARTIS AG Stock Novartis AG
+10.63% 209B
AMGEN INC. Stock Amgen Inc.
+9.32% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SONN Stock
  4. Financials Sonnet BioTherapeutics Holdings, Inc.